46 results on '"Capone, Emily"'
Search Results
2. HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target
3. Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma
4. Extracellular Vesicles in Glioblastoma: Biomarkers and Therapeutic tools
5. Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
6. ABCC3 is a novel target for the treatment of pancreatic cancer
7. LGALS3BP is a potential target of antibody‐drug conjugates in oral squamous cell carcinoma.
8. Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates
9. EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
10. HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications
11. LGALS3BP is a potential target of antibody‐drug conjugates in oral squamous cell carcinoma
12. HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
13. Extracellular LGALS3BP : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
14. Visualizing Galectin-3 Binding Protein Expression with ImmunoPET
15. Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac
16. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
17. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
18. EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo
19. Cover Image, Volume 123, Number 1, January 2022
20. MYC regulates metabolism through vesicular transfer of glycolytic kinases
21. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration
22. Supplementary figure Legends from MYC Regulates metabolism through vesicular transfer of glycolytic kinases
23. Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
24. EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
25. Normal breathing releases SARS-CoV-2 into the air
26. EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
27. Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
28. Antibody-Drug Conjugates: The New Frontier of Chemotherapy
29. HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
30. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration.
31. Additional file 1: of Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
32. Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
33. Abstract 238: Therapeutic activity of the non-internalizing antibody drug conjugate 1959-sss/DM3 targeting galectin3-binding protein in human neuroblastoma
34. EV20-sss-vc/MMAF, an HER-3 targeting antibody-drug conjugate displays antitumor activity in liver cancer.
35. Targeting trastuzumab and T-DM1 resistant breast cancer cells with EV20/MMAF, an Antibody-Drug Conjugated against HER-3
36. EV20/MMAF muestra actividad antitumoral potente y específica en cáncer de mama HER2 positivo
37. Abstract 741: Targeting trastuzumab and T-DM-1 resistant breast cancer cells with EV20/MMAF, an antibody drug-conjugate against HER3
38. Abstract 748: Non-internalizing site-specific antibody-drug conjugates based on maytansinoids display curative properties
39. EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
40. Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
41. Abstract 41: An Antibody Drug Conjugate targeting HER-3 demonstrates promising antitumor efficacy in a wide range of human cancer
42. Abstract 40: Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
43. Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac.
44. HER-3: hub for escape mechanisms
45. ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
46. Abstract 5437: Dual targeting of ErbB-2 and ErbB-3: A new potential strategy for the treatment of pancreatic cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.